PAREXEL Early Phase Symposium
Wednesday, 19 October 2016 | 09.30 - 17.00
Dorint an der Messe Basel | Basel Switzerland


View full agenda and topics here.

Basel symposium highlights:
  • Key considerations for a strong early development plan
  • How and why Biomarkers can provide value to your programs
    Justin J. Devine, Chief Medical Officer, Synexa Life Sciences
  • Clinical and Commercial Aspects of PK/PD Modeling
  • Learn about PAREXEL Early Phase and Biopharm Unit
  • How to find a quality development partner to fund your asset’s development
    Claudia Graeve, PhD, Vice President,
    Health Advances LLC
  • What a potential licensing partner is looking for
    Anne-Kathrin Witt, Global BD & Licensing, Head Project Management and Search & Evaluations Cardio-Metabolic,
    Novartis Pharma AG
  • Coffee, lunch & drinks reception offered
To register, please complete the information below. A confirmation will be sent with details once your RSVP is processed.







By submitting this form, you consent to receive communications from PAREXEL.
Click here to customize your preferences or opt-out.

©2018 PAREXEL International Corp.
195 West Street Waltham, MA, 02451, USA • Tel: +1 781-487-9900
Privacy Policy | EU-US Privacy Shield Notice | Contact Us